Mucosal immunization with a Staphylococcus aureus IsdA-cholera toxin A 2/B chimera induces antigen-specific Th2-type responses in mice

Clinical and Vaccine Immunology

Volumn 18, Issue 9, 2011, Pages 1543-1551

  Arlian, Britni M ^a   Tinker, Juliette K ^a  

^a BOISE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CHOLERA TOXIN; CHOLERA TOXIN A2 SUBUNIT; CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 4; IRON REGULATED SURFACE DETERMINANT A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BACTERIUM ADHERENCE; CELL ADHESION; CELLULAR IMMUNITY; CHIMERA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOSTIMULATION; IN VITRO STUDY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; NOSE PROVOCATION TEST; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VACCINE PRODUCTION; WESTERN BLOTTING;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL ADHESION; CHOLERA TOXIN; CYTOKINES; DENDRITIC CELLS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; TH2 CELLS;

EID: 80052447250     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05146-11     Document Type: Article

References (62)

1. Agren, L. C., L. Ekman, B. Lowenadler, and N. Y. Lycke. 1997. Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit. J. Immunol. 158:3936-3946. (Pubitemid 127488754)
2. Anosova, N. G., et al. 2008. Cholera toxin, E. coli heat-labile toxin, and non-toxic derivatives induce dendritic cell migration into the follicle-associated epithelium of Peyer's patches. Mucosal Immunol. 1:59-67.
3. Ayalew, S., D. L. Step, M. Montelongo, and A. W. Confer. 2009. Intranasal vaccination of calves with Mannheimia haemolytica chimeric protein containing the major surface epitope of outer membrane lipoprotein PlpE, the neutralizing epitope of leukotoxin, and cholera toxin subunit B. Vet. Immunol. Immunopathol. 132:295-302.
4. Bagley, K. C., S. F. Abdelwahab, R. G. Tuskan, and G. K. Lewis. 2003. An enzymatically active a domain is required for cholera-like enterotoxins to induce a long-lived blockade on the induction of oral tolerance: New method for screening mucosal adjuvants. Infect. Immun. 71:6850-6856. (Pubitemid 37475314)
5. Bastiaens, P. I., I. V. Majoul, P. J. Verveer, H. D. Soling, and T. M. Jovin. 1996. Imaging the intracellular trafficking and state of the AB5 quaternary structure of cholera toxin. EMBO J. 15:4246-4253. (Pubitemid 26278707)
6. Brown, E. L., et al. 2009. The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin. Microbiol. Infect. 15:156-164.
7. Clarke, S. R., et al. 2009. Iron-regulated surface determinant protein A mediates adhesion of Staphylococcus aureus to human corneocyte envelope proteins. Infect. Immun. 77:2408-2416.
8. Clarke, S. R., et al. 2006. Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J. Infect. Dis. 193:1098-1108.
9. Clarke, S. R., et al. 2007. The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin. Cell Host Microbe 1:199-212. (Pubitemid 46706363)
10. Cong, Y., C. T. Weaver, and C. O. Elson. 1997. The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression. J. Immunol. 159:5301-5308. (Pubitemid 127470056)
11. Czerkinsky, C., N. Cuburu, M. N. Kweon, F. Anjuere, and J. Holmgren. 2011. Sublingual vaccination. Hum. Vaccin. 7:110-114.
12. Czerkinsky, C., M. W. Russell, N. Lycke, M. Lindblad, and J. Holmgren. 1989. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect. Immun. 57:1072-1077. (Pubitemid 19087848)
13. Deleo, F. R., M. Otto, B. N. Kreiswirth, and H. F. Chambers. 2010. Community- associated methicillin-resistant Staphylococcus aureus. Lancet 375: 1557-1568.
14. Diep, B. A., et al. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 367:731-739. (Pubitemid 43326291)
15. Dreesen, I. A., G. Charpin-El Hamri, and M. Fussenegger. 2010. Heat-stable oral alga-based vaccine protects mice from Staphylococcus aureus infection. J. Biotechnol. 145:273-280.
16. Eriksson, K., M. Fredriksson, I. Nordstrom, and J. Holmgren. 2003. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development. Infect. Immun. 71:1740-1747. (Pubitemid 36368702)
17. George-Chandy, A., et al. 2001. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infect. Immun. 69:5716-5725. (Pubitemid 32786510)
18. Gockel, C. M., and M. W. Russell. 2005. Induction and recall of immune memory by mucosal immunization with a non-toxic recombinant enterotoxin- based chimeric protein. Immunology 116:477-486. (Pubitemid 41713178)
19. Grigg, J. C., C. L. Vermeiren, D. E. Heinrichs, and M. E. Murphy. 2007. Haem recognition by a Staphylococcus aureus NEAT domain. Mol. Microbiol. 63:139-149. (Pubitemid 44968115)
20. Hagiwara, Y., et al. 2001. Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain. Vaccine 19:1652-1660. (Pubitemid 32175725)
21. Hajishengallis, G., S. Arce, C. M. Gockel, T. D. Connell, and M. W. Russell. 2005. Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: Applications for oral infections. J. Dent. Res. 84: 1104-1116. (Pubitemid 43827777)
22. Hajishengallis, G., S. K. Hollingshead, T. Koga, and M. W. Russell. 1995. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J. Immunol. 154:4322-4332.
23. Hajishengallis, G., S. M. Michalek, and M. W. Russell. 1996. Persistence of serum and salivary antibody responses after oral immunization with a bacterial protein antigen genetically linked to the A2/B subunits of cholera toxin. Infect. Immun. 64:665-667. (Pubitemid 26032846)
24. Hervouet, C., et al. 2010. Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract. Vaccine 28:5582-5590.
25. Holden, M. T., et al. 2004. Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. U. S. A. 101:9786-9791. (Pubitemid 38869314)
26. Holmgren, J., et al. 2005. Mucosal adjuvants and anti-infection and antiimmunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol. Lett. 97:181-188. (Pubitemid 40326949)
27. Holmgren, J., C. Czerkinsky, N. Lycke, and A. M. Svennerholm. 1994. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. Am. J. Trop. Med. Hyg. 50:42-54. (Pubitemid 24208667)
28. Jobling, M. G., and R. K. Holmes. 1992. Fusion proteins containing the A2 domain of cholera toxin assemble with B polypeptides of cholera toxin to form immunoreactive and functional holotoxin-like chimeras. Infect. Immun. 60:4915-4924.
29. Kallen, A. J., et al. 2010. Health care-associated invasive MRSA infections, 2005-2008. JAMA 304:641-648.
30. Kawamura, Y. I., et al. 2003. Cholera toxin activates dendritic cells through dependence on GM1-ganglioside which is mediated by NF-B translocation. Eur. J. Immunol. 33:3205-3212. (Pubitemid 37428353)
31. Kim, H. K., et al. 2010. IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge. Vaccine 28: 6382-6392.
32. Klein, E., D. L. Smith, and R. Laxminarayan. 2007. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg. Infect. Dis. 13:1840-1846. (Pubitemid 350248484)
33. Kluytmans, J. A., and H. F. Wertheim. 2005. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection 33:3-8. (Pubitemid 40585492)
34. Lee, S. F., S. A. Halperin, D. F. Salloum, A. MacMillan, and A. Morris. 2003. Mucosal immunization with a genetically engineered pertussis toxin S1 fragment- cholera toxin subunit B chimeric protein. Infect. Immun. 71:2272-2275. (Pubitemid 36368767)
35. Lewis, D. J., et al. 2009. Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin. PLoS One 4:e6999.
36. Li, X., et al. 2004. Use of translational fusion of the MrpH fimbrial adhesinbinding domain with the cholera toxin A2 domain, coexpressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilis. Infect. Immun. 72:7306-7310. (Pubitemid 39552402)
37. Liu, M., et al. 2008. Direct hemin transfer from IsdA to IsdC in the ironregulated surface determinant (Isd) heme acquisition system of Staphylococcus aureus. J. Biol. Chem. 283:6668-6676.
38. Lycke, N., T. Tsuji, and J. Holmgren. 1992. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADPribosyltransferase activity. Eur. J. Immunol. 22:2277-2281.
39. Majoul, I. V., P. I. Bastiaens, and H. D. Soling. 1996. Transport of an external Lys-Asp-Glu-Leu (KDEL) protein from the plasma membrane to the endoplasmic reticulum: Studies with cholera toxin in Vero cells. J. Cell Biol. 133:777-789. (Pubitemid 26160980)
40. Marinaro, M., et al. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155:4621-4629.
41. Mazmanian, S. K., H. Ton-That, K. Su, and O. Schneewind. 2002. An iron-regulated sortase anchors a class of surface protein during Staphylococcus aureus pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 99:2293-2298. (Pubitemid 34169054)
42. Mutsch, M., et al. 2004. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N. Engl. J. Med. 350:896-903. (Pubitemid 38252537)
43. Parish, C. R., M. H. Glidden, B. J. Quah, and H. S. Warren. 2009. Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation. Curr. Protoc. Immunol., chapter 4, unit 4.9. http://onlinelibrary .wiley.com/doi/10.1002/0471142735.im0409s84/full.
44. Pizza, M., et al. 2001. Mucosal vaccines: Nontoxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19:2534-2541. (Pubitemid 32234269)
45. Rebelatto, M. C., L. Siger, and H. Hogenesch. 2001. Kinetics and type of immune response following intranasal and subcutaneous immunisation of calves. Res. Vet. Sci. 71:9-15. (Pubitemid 33100037)
46. Sanchez, J., J. Holmgren, and A. M. Svennerholm. 1990. Recombinant fusion protein for simple detection of Escherichia coli heat-stable enterotoxinby GM1 enzyme-linked immunosorbent assay. J. Clin. Microbiol. 28:2175- 2177.
47. Schnitzler, A. C., J. M. Burke, and L. M. Wetzler. 2007. Induction of cell signaling events by the cholera toxin B subunit in antigen-presenting cells. Infect. Immun. 75:3150-3159. (Pubitemid 46870201)
48. Shen, Z., G. Reznikoff, G. Dranoff, and K. L. Rock. 1997. Cloned dendriticcells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158:2723-2730. (Pubitemid 127470530)
49. Stiles, B. G., A. R. Garza, R. G. Ulrich, and J. W. Boles. 2001. Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model. Infect. Immun. 69:2031-2036. (Pubitemid 32239666)
50. Stranger-Jones, Y. K., T. Bae, and O. Schneewind. 2006. Vaccine assembly from surface proteins of Staphylococcus aureus. Proc. Natl. Acad. Sci. U. S. A. 103:16942-16947. (Pubitemid 44737357)
51. Sultan, F., L. L. Jin, M. G. Jobling, R. K. Holmes, and S. L. Stanley, Jr. 1998. Mucosal immunogenicity of a holotoxin-like molecule containing the serinerich Entamoeba histolytica protein (SREHP) fused to the A2 domain of cholera toxin. Infect. Immun. 66:462-468. (Pubitemid 28074182)
52. Sun, J. B., C. Czerkinsky, and J. Holmgren. 2010. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scand. J. Immunol. 71:1-11.
53. Tacket, C., and D. A. Sack. 2008. Cholera vaccines, p. 127-138. In S. Plotkin, W. A. Orenstein, and P. A. Offit (ed.), Vaccines, 5th ed. Elsevier, New York, NY.
54. Taylor, J. M., and D. E. Heinrichs. 2002. Transferrin binding in Staphylococcusaureus: Involvement of a cell wall-anchored protein. Mol. Microbiol. 43:1603-1614. (Pubitemid 34595550)
55. Tinker, J. K., C. T. Davis, and B. M. Arlian. 2010. Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras. Protein Expr. Purif 74:16-23.
56. Tinker, J. K., J. L. Erbe, W. G. Hol, and R. K. Holmes. 2003. Cholera holotoxin assembly requires a hydrophobic domain at the A-B5 interface: Mutational analysis and development of an in vitro assembly system. Infect. Immun. 71:4093-4101. (Pubitemid 36753738)
57. Tinker, J. K., J. L. Erbe, and R. K. Holmes. 2005. Characterization of fluorescent chimeras of cholera toxin and Escherichia coli heat-labile enterotoxins produced by use of the twin arginine translocation system. Infect. Immun. 73:3627-3635. (Pubitemid 40745907)
58. Van Ginkel, F. W., et al. 2005. Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract. Infect. Immun. 73:6892-6902. (Pubitemid 41368858)
59. Verkaik, N. J., et al. 2010. Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia. Eur. J. Clin. Microbiol. Infect. Dis. 29:509-518.
60. Vermeiren, C. L., M. Pluym, J. Mack, D. E. Heinrichs, and M. J. Stillman. 2006. Characterization of the heme binding properties of Staphylococcus aureus IsdA. Biochemistry 45:12867-12875. (Pubitemid 44630873)
61. Wertheim, H. F., et al. 2004. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364:703-705. (Pubitemid 39140626)
62. Xu-Amano, J., et al. 1994. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine 12:903-911. (Pubitemid 24250284)